Summary
McKesson Corporation reported a significant increase in revenue for the quarter and six months ended September 30, 2004, driven primarily by its Pharmaceutical Solutions segment, which accounted for over 94% of consolidated revenues. This growth was fueled by market expansion, new institutional customers, and a significant contract with the Department of Veterans Affairs. However, net income and diluted earnings per share saw a considerable decline compared to the prior year. This decrease is largely attributed to lower operating profit in the Pharmaceutical Solutions segment, stemming from a reduction in volume-weighted price increases for U.S. pharmaceutical products and changes in vendor product incentives. The company also highlighted progress in its Medical-Surgical Solutions segment, partly due to the acquisition of Moore Medical Corp., and a slight revenue decline in Provider Technologies. McKesson continues to manage its financial resources actively, with improved cash flow from operations and the establishment of a new $1.3 billion revolving credit facility. Despite revenue growth, investors should note the pressure on gross margins, particularly in the Pharmaceutical Solutions segment, and the ongoing efforts to restructure distribution agreements towards a fee-for-service model.
Key Highlights
- 1Revenue increased by 19% year-over-year for the quarter ($19.9B) and 17% for the six months ($39.1B), primarily driven by the Pharmaceutical Solutions segment.
- 2Net income decreased by 45% for the quarter ($86.1M) and 20% for the six months ($249.7M) compared to the prior year.
- 3Diluted Earnings Per Share (EPS) decreased by 45% for the quarter ($0.29) and 20% for the six months ($0.84).
- 4Gross profit margin declined significantly, particularly in the Pharmaceutical Solutions segment, due to lower manufacturer price increases and changes in vendor incentives.
- 5McKesson entered into a new $1.3 billion five-year senior unsecured revolving credit facility in September 2004, terminating previous facilities.
- 6The company acquired Moore Medical Corp. for approximately $37 million in April 2004, contributing to the Medical-Surgical Solutions segment.
- 7Operating expenses as a percentage of revenue decreased due to leveraging fixed costs and productivity improvements, despite an overall increase in dollar amount.